Business

The US Patent and Trademark Office has issued US Patent No. 9,572,774, titled “Dry Powder Vancomycin Compositions and Associated Methods,” to inhaled drug developer Savara, Inc., the company said. In its statement, the company added,… Read more . . .

AstraZeneca will pay $45 million up front and up to $2.1 billion in milestone and commercial payments to Pieris Pharmaceuticals for development and commercialization rights to Pieris’s inhaled anticalin therapies, Pieris said. In the near… Read more . . .

The US National Institutes of Health (NIH) has published two funding opportunity announcements (FOAs) related to nasal delivery of CNS therapeutics. The projects described in FOAs RFA-DA-18-006 and RFA-DA-18-007 are both supported by Small Business… Read more . . .

Teva has launched both the AirDuo RespiClick fluticasone propionate/salmeterol DPI and an authorized generic version of the product in the US, the company said. The FDA approved 3 doses of AirDuo RespiClick for the treatment… Read more . . .

Invion has announced that Hong Kong based The Cho Group will acquire 15.03% of Invion for a total of A$656,682 through a private placement. A restructuring of Invion’s board will include the addition of two… Read more . . .

Respira Therapeutics has announced that United Therapeutics will fund the development of Respira’s RT234 DPI for the treatment of pulmonary hypertension. United Therapeutics will get an exclusive license for the product in North America and… Read more . . .

Medical Developments International (MVP) has announced distribution deals for its compact anti-static space chambers in the US and for its Penthrox methoxyflurane inhaler in Russia. All Walmart and Kmart pharmacies in the US will carry… Read more . . .

Amneal Pharmaceuticals initiated shipments of its generic version of Nasonex mometasone furoate nasal spray on April 4, 2017, the company said. According to Amneal, the mometasone furoate nasal spray is its “first pharmaceutical product in… Read more . . .

Vectura has announced that it will receive a €5 million milestone now that Bayer AG has launched the Breelib nebulizer for Ventavis iloprost inhalation solution in Poland. Breelib is an adaptation of Vectura’s FOX handheld… Read more . . .